Monodelphis domestica, also known as the laboratory opossum, is a marsupial native to South 35 America. At birth, these animals are developmentally equivalent to human embryos at 36 approximately 5 weeks of gestation which, when coupled with other characteristics including the 37 size of the animals, the development of a robust immune system during juvenile development, 38 and the relative ease of experimental manipulation, have made M. domestica a valuable model in 39 many areas of biomedical research. However, their suitability as models for infectious diseases, 40 especially diseases caused by viruses such as Zika virus (ZIKV), is currently unknown. Here, we 41 describe the replicative effects of ZIKV using a fetal intra-cerebral model of inoculation. Using 42 immunohistochemistry and in situ hybridization, we found that opossum embryos and fetuses are 43 susceptible to infection by ZIKV administered intra-cerebrally, that the infection persists long 44 term, and that the infection and viral replication consistently results in neural pathology and may 45 occasionally result in global growth restriction. These results demonstrate the utility of M. 46 domestica as a new animal model for investigating ZIKV infection in vivo. This new model will 47
7 146 analysis for between-group comparisons, as well as robust assessment of within-group variations 147 in outcome of ZIKV infection. 148 We emphasize the importance of being able to assess within-group variation in large 149 numbers of animals inoculated with ZIKV, for the purpose of modeling the major variations in syndrome is caused by ZIKV infection in only a minority of people [32] . 155 The purpose of this study was to assess the utility of M. domestica as an intra-cerebral 156 model for ZIKV neuropathogenesis by determining if ZIKV can replicate and persist in the 157 brains of young pups and, if so, to determine the nature and extent of the neuropathological 158 consequences by comparison with those observed in humans and other animal models. 159 We point out that the experiment reported here is not intended to model the complex 160 biological processes that lead to infection of brains of human embryos and fetuses with ZIKV, 161 typically beginning with the bite of a mosquito, replication in the mother, trans-placental transfer 162 to the embryo or fetus, replication in the embryo or fetus, followed by entry into the brain and 163 replication in the brain. Rather, our model obviates all of the variables and mechanistic 164 complexities that exist between the time of initial infection of the mother and entry of the virus 165 into the brain of the embryo or fetus. Via the use of this unique model, we can conduct high 166 throughput experiments to investigate short-term and long-term pathological effects of variation 167 in the number of PFU that enter the brain, the exact developmental time point at which they enter 8 168 the brain, and the genetic make-up of different ZIKV strains, in the absence of the many 169 confounding variables that exist in models of trans-placental infection of embryos and fetuses.
170

METHODS
171
Animals 172 The laboratory opossums used in this study were produced in the breeding colony maintained at 173 The University of Texas Rio Grande Valley and maintained under standard conditions [28] . 184 In the first experiment, M. domestica pups were inoculated with 5,000 PFU of ZIKV 185 PRVABC59 intra-cerebrally. Two litters at 2 and 3 days of age, respectively, were used, 186 hereafter referred to as Group 1 and Group 2. Each group contained three animals. At 19 days 187 post-inoculation, the animals were euthanized, and whole brains were collected, weighed, and 188 homogenized for virus titration. intra-cerebrally with 5,000 PFU of ZIKV as described above. Control animals, ranging in age 195 from 2-9 days, were inoculated with PBS. Seventy-two days after the inoculations, the animals 196 were euthanized, weighed, and measured; and brain tissue was collected for analysis by 197 immunohistochemistry and in situ hybridization. 199 ZIKV isolate PRVABC59 (a gift from Dr. Kenneth Plante at the WRCEVA repository at 200 UTMB) was used for the inoculations. Vero cells (CCL-81; ATCC, USA) were used for virus 201 titration, and C6/36 cells (CRL-1660; ATCC, USA) derived from Aedes albopictus were used to 202 amplify lyophilized virus for scale-up. Virus generated from the initial reconstituted lyophilized 203 stock was passaged once in C6/36 cells, and the resulting supernatant was clarified and purified 204 over a sucrose cushion. Virus supernatants were quantified in duplicate by plaque assay, as 205 described previously [33] . Aliquots were stored at -80°C for further use.
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Cells and viruses
206
Tissue fixation and sectioning 207 Dissected tissue was fixed in sterile PBS (Gibco, USA) + 4% formaldehyde solution and stored 208 at room temperature. Fixative was then cleared from tissue by performing three quick washes in 209 sterile PBS followed by three 10-min washes in sterile PBS. Next, the tissue was washed 1X for 210 5 min in a 25% methanol:PBS solution; washed 1X for 5 min in 50 % methanol:PBS solution; 10 211 and finally washed 3X for 5 min in 100% methanol. Tissue was stored at -20°C until needed. 
242
In situ hybridization 243 Mounted sections of tissue were incubated in RNase free PBST (sterile PBS + .01% Tween20) 244 for 5 min, 50% PBST: Hybridization buffer (50% formamide, 5X SSC, 100 µg/ml salmon 245 sperm, 0.1% Tween20, 100 µg/ml Heparin) for five min, then in hybridization buffer for 5 min.
246
New hybridization buffer was placed on the sections, and pre-hybridization was performed in a 247 small, airtight container at 56°C for 2 hours. The working probe solution was prepared by 248 adding ~200 ng of probe to 100 µl of hybridization buffer and then incubating at 90°C for 5 min, 249 after which the incubation tubes were placed on ice. The working probe solution was then 250 applied to tissue sections and incubated in an airtight container at 56°C for 16 -24 hours. Probes 251 were washed from the sections using a variety of wash times and numbers, with all washes using 252 hybridization buffer warmed to 56°C and all washes conducted at 56°C. The following protocol 253 was used to minimize non-specific signal: eight washes of 15 min each, followed by four washes 254 of 30 min each. The slides were then cooled to room temperature and washed 1X for 5 min in 255 50% PBTB: hybridization buffer, 3X for 5 min each in PBTB, 1X for 1 hour in PBTB (to block 12 256 non-specific protein binding). Slides were then incubated either for 1 hour at room temperature 257 or overnight at 4°C in 1:100 dilution of an HRP conjugated anti-DIG antibody and PBTB. This 258 antibody was removed by three quick washes, and then three 5-min washes in PBTB. Slides 259 were washed in 1X Tyramide buffer for 5 min. Fluorescent labelling was performed using the 260 AlexaFluor Superboost ® tyramide signal amplification kit (Thermo Fisher Scientific, USA) 261 following the manufacturer's instructions and using either the 546 or 647 markers. After the 262 tyramide reaction was stopped, excess reagent was removed by washing 3X quickly, then 3X for 263 10 min each in PBTB. DAPI and AlexaFluor 488 conjugated phalloidin were included in the first 264 long wash to label nuclei and cytoskeletal elements, respectively. Tissue was imaged using an 265 Olympus FV10i confocal microscope.
266
Pathology and NS1 Scoring of Tissues
267
Brain slices from all animals were prepared, stained, and visualized for detection of NS1 as 280 Viral replication was detected in two of the three animals from Group 1 (2 days old at the time of 281 inoculation), and one of the three animals from Group 2 (3 days old at the time of inoculation).
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The average titer was 1.8 X 10 4 PFU/g of brain tissue from the two 2-day old pups in which virus 283 was detected, while the titer from the single 3-day old pup that was infected was 4.3 X 10 4 PFU/g 284 of brain tissue ( Developmental effects of intra-cerebral inoculation 294 One animal (O9355) among the five littermates that were inoculated at 6 days of age and 295 euthanized at 80 days of age had much lower values for body weight, body length, and head 296 length and width, compared to those of its littermates ( Fig. 1; Fig. 2 animal with such severe growth restriction, although runts are produced on rare occasions. Also, 300 none of the 10 PBS-inoculated animals exhibited growth restriction.
301
Presence of viral protein and RNA in brains infected with ZIKV
302
The brains of the pups were fixed, sectioned, and stained for the presence of ZIKV NS1 protein.
303
Immunofluorescence microscopy showed that, in brains collected from all 16 ZIKV-inoculated 304 animals, anti-ZIKV monoclonal antibody directed against NS1 bound specifically to neuronal 305 cells, indicating that the brains were infected with ZIKV ( Fig. 3a, 3b) . The number of cells 306 visibly expressing NS1 was evaluated and scored based upon the number of nuclei displaying a 307 characteristic punctate staining pattern that we observed in all infected neural tissue samples 308 ( Fig. 1) . All infected animals showed the presence of NS1 within the brain sections, and the 309 amount of signal appeared to correlate to the pathology of the tissue. Animals that showed the 310 most severe pathology also had the highest number of NS1-fluorescing nuclei, while the samples 311 with more moderate and low pathology scores had low to moderate levels of NS1 expression 312 ( Fig. 1) . 313 Spearman's correlation coefficient between these semi-quantitative measures of brain pathology 314 and NS1 signal is 0.59 (P = 0.008 for a 1-tailed test of the null hypothesis that there is not a 315 positive correlation between the two measures). Brain tissue sections from each of the 10 316 animals inoculated with PBS exhibited no evidence of ZIKV (Fig. 3c) . To further confirm the 317 presence of ZIKV replication, an in-situ hybridization assay was conducted on brain sections of 318 O9355 to detect ZIKV vRNA using NS5 as a target gene. The results showed a strong signal for 319 ZIKV NS5 RNA in the cerebellum (Fig. 4) . 322 In addition to demonstrating the presence of ZIKV RNA and protein in the brains of infected 323 pups, images of the fixed neural tissues collected from infected opossum pups were also 324 evaluated based upon the observable cell morphology and scored for severity of disease ( Fig. 1) . 325 Most of the brain slices showed either a mild or moderate pathology; however, three samples 326 displayed a discontiguous, spongiform-like pathology with large gaps between cells (i.e., a 327 dramatic reduction in density of cells), along with large clumps of DAPI-stained (blue) DNA, 328 which apparently had been released from cells as they died and which had aggregated into large 329 extra-cellular clumps (Fig. 5a) . Further examination of brains with this spongiform morphology 330 showed the presence of high levels of ZIKV NS1 protein (Fig.5b) . The cerebellum slices from 331 the PBS-inoculated control animals had a uniform, contiguous appearance with little to no gaps 332 between cells, no apparent destruction or cell death, and no extracellular DNA ( Fig. 5c-d) . 
Pathological consequences of ZIKV infection in the brain
381
A critical finding of our study was the correlation between pathology and level of NS1 382 signal in the brains of ZIKV-inoculated pups. We consider the correlation of 0.59 (P = 0.008) to 383 be exceptionally high, given that these continuously distributed phenotypes were each 384 subdivided into discrete categories (four for pathology, ranging from 0 to 3; and three for NS1, 385 ranging from 1 to 3, since no ZIKV-inoculated pups scored 0 for presence of NS1). The only 386 three animals that had brains with a spongiform-like pathology (score of 3) all also had the 387 highest score (i.e., 3) for NS1. The only two ZIKV-inoculated pups that had no observable brain 388 pathology (score of 0) had the lowest score for NS1 (i.e., 1) for animals that were inoculated with 389 ZIKV. These results establish that 1) some animals in which ZIKV has been present in their 18 390 brains since the embryo or fetal stage exhibit no obvious brain pathology, 2) there is variation 391 among littermates in extent of NS1 detected in the brains and consequent extent of pathology, 3) 392 pups as young as 4 days of age and pups as old as 20 days of age at the time of inoculation can 393 develop severe (spongiform-like) brain pathology. Those ages are developmentally equivalent to 394 humans at 8 weeks post conception to 20 weeks post conception (i.e., mid gestation) [26] .
395
Another critical finding was the reduction in overall body size of one infected animal 396 compared to its ZIKV-infected littermates or mock-infected control animals. Surprisingly, the 397 brain of the affected animal (O9355) exhibited only mild pathology (score of 1, see Figure 1 ),
398
suggesting that growth restriction may not be correlated with overall brain pathology, but rather 399 might be a consequence of a localized perturbation in brain development caused by ZIKV from the WHO and CDC originally highlighted microcephaly as the major concern with vertical 406 transmission of ZIKV infection in pregnancy, more recent studies refer to Congenital Zika human decidua) and placental acute chorioamnionitis [39] . Therefore, evaluation of the 414 opossum model using the expanded criteria of CZS (as has been suggested by others to include, 415 but not be limited to, microcephaly), may allow for a more comprehensive understanding of the 416 neurotropism of ZIKV in the fetal brain. In the opossum model, we observed several 417 manifestations of CZS to include: 1) overall reduction in total body size and weight of one 418 animal; 2) the presence of ZIKV NS1 protein as well as NS5 vRNA in the brains of infected 419 pups; and 3) reductions in total number of glial cells, gliosis, hypoplasia, and cellular damage.
420
As discussed above, we also observed a spongiform-like pathology in three infected animals. And, as shown recently, some of the symptoms described in the transgenic murine fetal 433 models do not result in development of microcephaly, suggesting that there may be other factors 434 that influence neurological outcomes in transgenic murine models. For example, studies using 20 435 pregnant C57BL/6 (Ifnar1-/-) dams infected with ZIKV showed fetal brain damage in the pups; 436 however, no progression to microcephaly was observed [40] .
437
The introduction of ZIKV to the Americas has been followed by a steady spread of the 438 virus, tied to the range of the arthropod vector which has also increased in recent years [41] .
439
While ZIKV infection rates are certain to rise and fall cyclically, dependent at least in part on 440 weather patterns (particularly rainfall patterns and consequent mosquito density), it is expected 441 that the overall incidence of human infection will increase as more people are exposed to ZIKV of several putative vaccine candidates has also begun [43] . While these techniques probably 446 represent the best-case approach for dealing with ZIKV, the release of genetically modified 447 organisms is a topic that requires intense study and oversight by the FDA before it is approved.
448
Furthermore, the efforts to develop and license a ZIKV vaccine will require at least several more 449 years before such a product could become commercially available. As such, the development 450 and characterization of the major aspects of ZIKV biology, including the neurovirulence and 451 interactions between the immune system and ZIKV, will be required in order to fully support animals were euthanized, and photographs and measurements (Fig. 1) of the heads were taken. 
